To evaluate the efficacy and safety of traditional Chinese medicine(TCM)in treating postoperative gastric cancer. We searched CNKI

VIP

WanFang (2001 to 2010) for randomized control trials about traditional Chinese medicine plus chemotherapy in the treatment of postoperative gastric cancer.Trial screening

quality assessment of included trials

and data extract were conducted. Statistical analysis was conductedby using RevMan 5.0 software. A total of 21 randomized controlled trials were included

meta analysis showed

① KPS score has 10 RCTs. 5 RCTs of classification variables no heterogeneity

KPS score 2.35

95%CI(1.78

3.10)

P<0.01]

5 RCTs of continuous variables no heterogeneity

KPS score

the differences are significant. ② Immune function 5 RCTs have heterogeneity and use random effects model.CD3 CD4

CD4/CD8 . The differences are significant. ③ Survival 3 RCTs have no heterogeneity

and use fixed effects model. One year survival rate is

2 year survival rate

3 year survival rate . The differences are significant. ④ Gastrointestinal reaction 5 RCTs have no heterogeneity

and use fixed effects model. Bad appetite above Ⅱ degrees is

Nausea and vomiting above Ⅱ degrees are . The differences are significant. ⑤ Blood toxicity 7 RCTs have no heterogeneity

and use fixed effects model. Leucopenia reduce above Ⅱ degrees

HB reduce above Ⅱ degrees

PLT reduce above Ⅱ degrees . The differences are significant. Traditional Chinese medicine plus chemotherapy is effective in curing postoperative gastric cancer. It can improve KPS score

immune function and survival rate

and reduce gastrointestinal reaction and blood toxicity.But the quality of studies is low

more large-scale multi-center randomized trials are needed.